Rchr
J-GLOBAL ID:201801016038504519
Update date: Sep. 25, 2024
Yuji Shimura
シムラ ユウジ | Yuji Shimura
Affiliation and department:
Research field (1):
Hematology and oncology
Research keywords (1):
hematology
Research theme for competitive and other funds (2):
- 2022 - 2025 miRNA inhibitor cocktail for suppressing MDSC function in hematologic malignancy
- 2018 - 2021 Molecular mechanisms underlying the induction of myeloid-derived suppressor cells in multiple myeloma
Papers (150):
-
Yutaka Shimazu, Junya Kanda, Teruhito Takakuwa, Yoshiyuki Onda, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, et al. The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients. Annals of hematology. 2024
-
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients. Cancer immunology, immunotherapy : CII. 2024. 73. 7. 135-135
-
Wakana Hashiro, Akihiro Miyashita, Yuka Kawaji-Kanayama, Haruya Okamoto, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Junya Kuroda. Good's Syndrome With Pure Red Cell Aplasia and Subclinical Myasthenia Gravis: A Case Report and Review of Literature. Cureus. 2024. 16. 5. e59654
-
Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, et al. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. Annals of hematology. 2024
-
Daisuke Ide, Takahiro Fujino, Tsutomu Kobayashi, Aya Egashira, Akihiro Miyashita, Kentaro Mizuhara, Reiko Isa, Taku Tsukamoto, Shinsuke Mizutani, Hitoji Uchiyama, et al. Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio. International journal of hematology. 2024
more...
MISC (84):
-
羽白稚菜, 宮下明大, 水原健太郎, 金山悠加, 藤野貴大, 塚本拓, 水谷信介, 志村勇司, 黒田純也. 赤芽球癆と潜在性重症筋無力症を合併したGood症候群. 臨床血液. 2024. 65. 2
-
小倉圭史, 藤野貴大, 知念祥太郎, 宮下明大, 金山悠加, 塚本拓, 水谷信介, 志村勇司, 黒田純也. ベネトクラクス・リツキシマブ(VR)併用療法が奏効したRichter症候群. 臨床血液. 2023. 64. 2
-
加藤大思, 服部雄, 藤野貴大, 大西朗生, 塚本拓, 岡本明也, 前倉知佳, 長田浩明, 伊佐怜子, 木元弥生, et al. Extranodal NK/T-cell lymphoma with CNS invasion successfully treated with RIST. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
-
宮下明大, 知念祥太郎, 小倉圭史, 村尾泰一, 井上祐, 新山侑生, 井出大輔, 長田浩明, 岡本明也, 村松彩子, et al. Management of adverse events with Tisagenlecleucel for relapsed/refractory large B cell lymphomas. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
-
知念祥太郎, 宮下明大, 小倉圭史, 村尾泰一, 井上祐, 新山侑生, 井出大輔, 長田浩明, 岡本明也, 村松彩子, et al. Tisagenlecleucel for refractory large B cell lymphomas in Kyoto Prefectural University of Medicine. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
more...
Education (3):
- 2009 - 2013 Kyoto Prefectural University of Medicine Graduate School of Medical Science
- 2000 - 2006 Kyoto Prefectural University of Medicine
- 1995 - 1999 Kyoto University Faculty of Pharmaceutical Sciences
Professional career (1):
Work history (8):
- 2022/04 - 現在 Kyoto Prefectural University of Medicine
- 2021/04 - 2022/03 Kyoto Prefectural University of Medicine Hematology and Oncology
- 2017/01 - 2021/03 Kyoto Prefectural University of Medicine
- 2016/04 - 2016/12 Kyoto Prefectural University of Medicine
- 2013/04 - 2016/03 Kyoto Prefectural University of Medicine
- 2009/04 - 2013/03 Kyoto Prefectural University of Medicine
- 2008/04 - 2009/03 大津市民病院 内科 専攻医
- 2006/04 - 2008/03 大津市民病院 初期研修医
Show all
Association Membership(s) (6):
THE JAPANESE SOCIETY OF HEMATOLOGY
, 日本リンパ網内系学会
, 日本臨床腫瘍学会
, 日本造血細胞移植学会
, 日本輸血・細胞治療学会
, 日本内科学会
Return to Previous Page